Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Candidates for Surgical Treatment”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Not applicableLooking for participantsNCT03893916
What this trial is testing

MEG Versus EEG HR for the Localization of the Epileptogenic Zone as Part of the Pre-surgical Assessment of Epilepsy

Who this might be right for
Drug-resistant EpilepsyCandidates for Surgical TreatmentEpilepsy
Hospices Civils de Lyon 100
Testing effectiveness (Phase 2)Looking for participantsNCT06758882
What this trial is testing

Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PET

Who this might be right for
High Risk Prostate Cancer
Marco Oderda 94
Early research (Phase 1)Study completedNCT01240460
What this trial is testing

Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection

Who this might be right for
GlioblastomaAstrocytoma, Grade IV
Sanofi 40
Testing effectiveness (Phase 2)Study completedNCT03472053
What this trial is testing

BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer Stage IIIB
BioMarck Pharmaceuticals, Ltd. 60
Testing effectiveness (Phase 2)Ended earlyNCT01861054
What this trial is testing

Pilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast Cancer

Who this might be right for
Breast Cancer
Dompé Farmaceutici S.p.A 20
Testing effectiveness (Phase 2)Looking for participantsNCT06048484
What this trial is testing

Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Gulam Manji 60
Not applicableStudy completedNCT03976674
What this trial is testing

A Preoperative Cognitive Behavioural Therapy Program Based on Self-determination Theory for Bariatric Surgery Candidates

Who this might be right for
Bariatric Surgery CandidateObesity
Lille Catholic University 94
Not applicableEnded earlyNCT01100866
What this trial is testing

Study of POMELLA™ Extract to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Vancouver Coastal Health 1
Not applicableActive Not RecruitingNCT04198870
What this trial is testing

MitraClip REPAIR MR Study

Who this might be right for
Mitral Valve Regurgitation
Abbott Medical Devices 500
Not applicableActive Not RecruitingNCT06436313
What this trial is testing

DBS Virtual Learning Experience

Who this might be right for
Parkinson Disease
University of Toronto 60
Testing effectiveness (Phase 2)Study completedNCT02882308
What this trial is testing

Preoperative Administration of Olaparib With Cisplatin or With Durvalumab or Alone or no Tratment in Patients Who Are Candidates for Surgery of Carcinoma of the Head and Neck.

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Hellenic Cooperative Oncology Group 41
Not applicableUnknownNCT02878447
What this trial is testing

The Utility of Radiotherapy in the Management of Haemoptysis Secondary to Aspergillomata and Structural Lung Diseases

Who this might be right for
Haemoptysis
University of Stellenbosch 40
Not applicableActive Not RecruitingNCT06721897
What this trial is testing

Effectiveness of a Prehabilitation Program for Hip or Knee Arthroplasty Surgery.

Who this might be right for
PrehabilitationKnee OsteoarthritisHip Osteoarthritis+1 more
University of Jaén 44
Testing effectiveness (Phase 2)Study completedNCT02289456
What this trial is testing

Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Followed by Nab-Paclitaxel for First Line Treatment of NSCLC Subjects With ECOG PS 2

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Celgene 40
Testing effectiveness (Phase 2)Study completedNCT01767792
What this trial is testing

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

Who this might be right for
Neurofibromatosis Type 2Progressive Vestibular Schwannomas
University of Alabama at Birmingham 22
Not applicableUnknownNCT00966511
What this trial is testing

Vibration Response Imaging (VRI) in Patients Who Are Potential Candidates for Surgical Resection

Who this might be right for
Lung Cancer
Deep Breeze 200
Not applicableActive Not RecruitingNCT06862648
What this trial is testing

Evaluating SUI-100™, A Non-Invasive Device for the Treatment of Stress Urinary Incontinence

Who this might be right for
Stress Urinary Incontinence (SUI)
Acoustic Wave Cell Therapy, Inc. 130
Early research (Phase 1)Active Not RecruitingNCT04391049
What this trial is testing

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery

Who this might be right for
Advanced Esophageal AdenocarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaClinical Stage II Esophageal Adenocarcinoma AJCC v8+30 more
NRG Oncology 16
Not applicableEnded earlyNCT00370695
What this trial is testing

Spinal Cord Stimulation for Chronic and Intractable Back Pain

Who this might be right for
Back Pain
Boston Scientific Corporation 15
Early research (Phase 1)Active Not RecruitingNCT04609592
What this trial is testing

Study of PRRT in Metastatic, WHO Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
Stanford University 10
Next Page